首页 > 最新文献

Clinical Nuclear Medicine最新文献

英文 中文
18F-FAPI-42 PET/MRI in the Evaluation of Glioma Recurrence: Comparison With 11C-MET PET/MRI and Contrast-enhanced MRI. 18F-FAPI-42 PET/MRI评价胶质瘤复发:与11C-MET PET/MRI和增强MRI的比较
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-05 DOI: 10.1097/RLU.0000000000006220
Jinju Sun, Yi Luo, Wenjie Gong, He Long, Jiaying Li, Jiantao Ran, Guoan Luo, Renxiang Xia, Xin Li, Xiao Chen

Background: This study aims to evaluate the diagnostic value of 18F-FAPI-42 PET in differentiating glioma recurrence from treatment-related changes, with comparative analyses against 11C-MET PET and contrast-enhanced MRI (CE-MRI).

Patients and methods: In this prospective study, patients with suspected glioma recurrence underwent concurrent 18F-FAPI-42 PET/MRI, 11C-MET PET/MRI, and CE-MRI examinations. Diagnostic performance for differentiating tumor recurrence was evaluated and compared across imaging modalities using McNemar test. Wilcoxon rank-sum tests were used to assess differences in SUVmax and tumor-to-background ratios (TBR) between glioma recurrence and treatment-related changes. Receiver operating characteristic curve analysis was performed to determine optimal cutoff values and compare the diagnostic efficacy of SUVmax and TBR through area under the curve (AUC) metrics.

Results: Among the 76 suspected glioma recurrence patients, 59 were diagnosed with recurrence and 17 had treatment-related changes. When distinguishing between recurrence and treatment-related changes, the accuracy and sensitivity of 18F-FAPI-42 PET were comparable to those of 11C-MET PET and CE-MRI (accuracy: 80.26% vs 86.84% vs 78.95%, respectively, all P > 0.05; sensitivity: 89.83% vs 93.22% vs 98.31%, respectively, all P > 0.05), but the specificity of 18F-FAPI-42 PET was significantly higher than that of CE-MRI (47.06% vs 11.76%, P = 0.031). The semiquantitative analysis of PET parameters showed that SUVmax and TBR of 18F-FAPI-42 PET and 11C-MET PET in glioma recurrence were significantly higher than treatment-related changes (all P < 0.05). The diagnostic performance of 18F-FAPI-42 PET TBR is outstanding (AUC: 0.940), higher than 11C-MET SUVmax and TBR (AUC: 0.842 and 0.851, P = 0.099 and 0.080), and significantly better than 18F-FAPI-42 SUVmax (AUC: 0.668, P < 0.001).

Conclusions: The diagnostic efficacy of 18F-FAPI-42 PET for glioma recurrence is comparable to 11C-MET PET, and its specificity superior to CE-MRI. 18F-FAPI-42 PET has a high TBR and advantages in delineating glioma boundaries, which may provide valuable information for therapeutic decision-making.

背景:本研究旨在评价18F-FAPI-42 PET在鉴别胶质瘤复发与治疗相关改变中的诊断价值,并与11C-MET PET和对比增强MRI (CE-MRI)进行对比分析。患者和方法:在这项前瞻性研究中,疑似胶质瘤复发的患者同时进行了18F-FAPI-42 PET/MRI, 11C-MET PET/MRI和CE-MRI检查。采用McNemar试验评估和比较不同成像方式对肿瘤复发的诊断性能。使用Wilcoxon秩和检验来评估胶质瘤复发和治疗相关变化之间SUVmax和肿瘤-背景比(TBR)的差异。进行受试者工作特征曲线分析以确定最佳临界值,并通过曲线下面积(AUC)指标比较SUVmax和TBR的诊断效果。结果:76例疑似胶质瘤复发患者中,59例确诊复发,17例出现治疗相关改变。在区分复发和治疗相关改变时,18F-FAPI-42 PET的准确性和敏感性与11C-MET PET和CE-MRI相当(准确性分别为80.26% vs 86.84% vs 78.95%,均P < 0.05;敏感性分别为89.83% vs 93.22% vs 98.31%,均P < 0.05),但18F-FAPI-42 PET的特异性明显高于CE-MRI (47.06% vs 11.76%, P = 0.031)。PET参数半定量分析显示,18F-FAPI-42 PET和11C-MET PET在胶质瘤复发中的SUVmax和TBR显著高于治疗相关变化(均P < 0.05)。18F-FAPI-42 PET TBR诊断效能突出(AUC: 0.940),高于11C-MET SUVmax和TBR (AUC: 0.842和0.851,P = 0.099和0.080),且显著优于18F-FAPI-42 SUVmax (AUC: 0.668, P < 0.001)。结论:18F-FAPI-42 PET对胶质瘤复发的诊断效果与11C-MET PET相当,特异性优于CE-MRI。18F-FAPI-42 PET具有高TBR和划定胶质瘤边界的优势,可能为治疗决策提供有价值的信息。
{"title":"18F-FAPI-42 PET/MRI in the Evaluation of Glioma Recurrence: Comparison With 11C-MET PET/MRI and Contrast-enhanced MRI.","authors":"Jinju Sun, Yi Luo, Wenjie Gong, He Long, Jiaying Li, Jiantao Ran, Guoan Luo, Renxiang Xia, Xin Li, Xiao Chen","doi":"10.1097/RLU.0000000000006220","DOIUrl":"https://doi.org/10.1097/RLU.0000000000006220","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the diagnostic value of 18F-FAPI-42 PET in differentiating glioma recurrence from treatment-related changes, with comparative analyses against 11C-MET PET and contrast-enhanced MRI (CE-MRI).</p><p><strong>Patients and methods: </strong>In this prospective study, patients with suspected glioma recurrence underwent concurrent 18F-FAPI-42 PET/MRI, 11C-MET PET/MRI, and CE-MRI examinations. Diagnostic performance for differentiating tumor recurrence was evaluated and compared across imaging modalities using McNemar test. Wilcoxon rank-sum tests were used to assess differences in SUVmax and tumor-to-background ratios (TBR) between glioma recurrence and treatment-related changes. Receiver operating characteristic curve analysis was performed to determine optimal cutoff values and compare the diagnostic efficacy of SUVmax and TBR through area under the curve (AUC) metrics.</p><p><strong>Results: </strong>Among the 76 suspected glioma recurrence patients, 59 were diagnosed with recurrence and 17 had treatment-related changes. When distinguishing between recurrence and treatment-related changes, the accuracy and sensitivity of 18F-FAPI-42 PET were comparable to those of 11C-MET PET and CE-MRI (accuracy: 80.26% vs 86.84% vs 78.95%, respectively, all P > 0.05; sensitivity: 89.83% vs 93.22% vs 98.31%, respectively, all P > 0.05), but the specificity of 18F-FAPI-42 PET was significantly higher than that of CE-MRI (47.06% vs 11.76%, P = 0.031). The semiquantitative analysis of PET parameters showed that SUVmax and TBR of 18F-FAPI-42 PET and 11C-MET PET in glioma recurrence were significantly higher than treatment-related changes (all P < 0.05). The diagnostic performance of 18F-FAPI-42 PET TBR is outstanding (AUC: 0.940), higher than 11C-MET SUVmax and TBR (AUC: 0.842 and 0.851, P = 0.099 and 0.080), and significantly better than 18F-FAPI-42 SUVmax (AUC: 0.668, P < 0.001).</p><p><strong>Conclusions: </strong>The diagnostic efficacy of 18F-FAPI-42 PET for glioma recurrence is comparable to 11C-MET PET, and its specificity superior to CE-MRI. 18F-FAPI-42 PET has a high TBR and advantages in delineating glioma boundaries, which may provide valuable information for therapeutic decision-making.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18 F-FDG PET/CT and 68 Ga-Pentixafor PET/CT Findings of Gastric Mucosa-associated Lymphoid Tissue Lymphoma Transformation to Diffuse Large B-cell Lymphoma. 胃黏膜相关淋巴组织淋巴瘤向弥漫性大b细胞淋巴瘤转化的18F-FDG PET/CT和68ga - pentxafor PET/CT表现
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-05-13 DOI: 10.1097/RLU.0000000000005957
Zitong Zhang, Hexiao Huang, Chong Jiang, Hongxi Wang, Rong Tian

A 66-year-old man with a pathology-confirmed gastric mucosa-associated lymphoid tissue (MALT) lymphoma underwent imaging with both 68 Ga-pentixafor and 18 F-FDG PET/CT. The 18 F-FDG PET/CT demonstrated intense FDG uptake in the gastric lesion, whereas the 68 Ga-pentixafor PET/CT showed only minimal tracer uptake. Subsequent histopathologic evaluation confirmed a transformation into aggressive diffuse large B-cell lymphoma (DLBCL). This case underscores the importance of recognizing atypical imaging patterns to identify histologic transformation and guide timely clinical intervention.

66岁男性,病理证实为胃黏膜相关淋巴组织(MALT)淋巴瘤,行68ga - pentxafor和18F-FDG PET/CT检查。18F-FDG PET/CT显示胃病变处FDG摄取强烈,而68ga - pentxapet /CT显示示踪剂摄取极少。随后的组织病理学检查证实为侵袭性弥漫性大b细胞淋巴瘤(DLBCL)。本病例强调了识别非典型影像学模式以识别组织学转变和指导及时临床干预的重要性。
{"title":"18 F-FDG PET/CT and 68 Ga-Pentixafor PET/CT Findings of Gastric Mucosa-associated Lymphoid Tissue Lymphoma Transformation to Diffuse Large B-cell Lymphoma.","authors":"Zitong Zhang, Hexiao Huang, Chong Jiang, Hongxi Wang, Rong Tian","doi":"10.1097/RLU.0000000000005957","DOIUrl":"10.1097/RLU.0000000000005957","url":null,"abstract":"<p><p>A 66-year-old man with a pathology-confirmed gastric mucosa-associated lymphoid tissue (MALT) lymphoma underwent imaging with both 68 Ga-pentixafor and 18 F-FDG PET/CT. The 18 F-FDG PET/CT demonstrated intense FDG uptake in the gastric lesion, whereas the 68 Ga-pentixafor PET/CT showed only minimal tracer uptake. Subsequent histopathologic evaluation confirmed a transformation into aggressive diffuse large B-cell lymphoma (DLBCL). This case underscores the importance of recognizing atypical imaging patterns to identify histologic transformation and guide timely clinical intervention.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"1181-1182"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FDG PET/CT in a Case of Primary Ewing Sarcoma of the Uterus. 子宫原发性尤文氏肉瘤1例FDG PET/CT分析。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-06-24 DOI: 10.1097/RLU.0000000000006036
Jiani He, Aisheng Dong, Xue Zhang

A 23-year-old woman presented with prolonged menstruation for 10 days. Pelvic ultrasound showed multiple masses in the uterus, suspicious for leiomyomas. Pelvic MRI showed an irregular multinodular uterine mass involving the cervix, and bilateral enlarged extrailiac lymph nodes, suggesting uterine malignancy with lymph node metastases. FDG PET/CT showed heterogeneous activity of the uterine mass and multiple FDG-avid lymph nodes in the bilateral pelvic and retroperitoneal regions, suggesting uterine malignancy with multiple lymph node metastases. Hysterectomy, bilateral salpingo-oophorectomy, and pelvic and retroperitoneal lymph node dissection revealed EWSR1-rearranged Ewing sarcoma of the uterus and no malignancy in the resected lymph nodes.

一名23岁女性,月经延长10天。盆腔超声示子宫内多发肿块,怀疑为平滑肌瘤。盆腔MRI示不规则多结节性子宫肿块累及子宫颈,双侧腹腔外淋巴结肿大,提示子宫恶性肿瘤伴淋巴结转移。FDG PET/CT显示双侧盆腔及腹膜后区域子宫肿块及多发FDG阳性淋巴结异质性活动,提示子宫恶性肿瘤伴多发淋巴结转移。子宫切除术、双侧输卵管卵巢切除术、盆腔及腹膜后淋巴结清扫显示ewsr1重排子宫尤文氏肉瘤,切除淋巴结无恶性肿瘤。
{"title":"FDG PET/CT in a Case of Primary Ewing Sarcoma of the Uterus.","authors":"Jiani He, Aisheng Dong, Xue Zhang","doi":"10.1097/RLU.0000000000006036","DOIUrl":"10.1097/RLU.0000000000006036","url":null,"abstract":"<p><p>A 23-year-old woman presented with prolonged menstruation for 10 days. Pelvic ultrasound showed multiple masses in the uterus, suspicious for leiomyomas. Pelvic MRI showed an irregular multinodular uterine mass involving the cervix, and bilateral enlarged extrailiac lymph nodes, suggesting uterine malignancy with lymph node metastases. FDG PET/CT showed heterogeneous activity of the uterine mass and multiple FDG-avid lymph nodes in the bilateral pelvic and retroperitoneal regions, suggesting uterine malignancy with multiple lymph node metastases. Hysterectomy, bilateral salpingo-oophorectomy, and pelvic and retroperitoneal lymph node dissection revealed EWSR1-rearranged Ewing sarcoma of the uterus and no malignancy in the resected lymph nodes.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"1206-1208"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Scallop-shaped Photopenic Region in the Urinary Bladder Area on Tc-99m MDP Bone Scan Caused by a Uterine Cervical Leiomyoma. 宫颈平滑肌瘤所致Tc-99m MDP骨扫描膀胱区扇贝形光衰区。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-07-11 DOI: 10.1097/RLU.0000000000006049
Guoqiang Wang, Xinfeng Liu, Zengmei Si, Zenghua Wang, Xufu Wang

A 46-year-old woman with right breast invasive ductal carcinoma and sternalgia underwent Tc-99m methylene diphosphonate (MDP) whole-body bone scintigraphy, on which a scallop-shaped photopenic region in the urinary bladder area was found, besides increased radioactivity in the sternum region and both breasts. By reviewing a previous CT scan, a pelvic mass oppressing the right wall of the urinary bladder was noted, which was confirmed to be a rare uterine cervical leiomyoma by biopsy.

46岁女性右乳浸润性导管癌伴胸痛行Tc-99m二膦酸亚甲基(MDP)全身骨显像,除胸骨及双乳放射性增高外,膀胱区见扇贝形光衰区。通过回顾既往CT扫描,发现盆腔肿块压迫膀胱右壁,活检证实为罕见的宫颈平滑肌瘤。
{"title":"A Scallop-shaped Photopenic Region in the Urinary Bladder Area on Tc-99m MDP Bone Scan Caused by a Uterine Cervical Leiomyoma.","authors":"Guoqiang Wang, Xinfeng Liu, Zengmei Si, Zenghua Wang, Xufu Wang","doi":"10.1097/RLU.0000000000006049","DOIUrl":"10.1097/RLU.0000000000006049","url":null,"abstract":"<p><p>A 46-year-old woman with right breast invasive ductal carcinoma and sternalgia underwent Tc-99m methylene diphosphonate (MDP) whole-body bone scintigraphy, on which a scallop-shaped photopenic region in the urinary bladder area was found, besides increased radioactivity in the sternum region and both breasts. By reviewing a previous CT scan, a pelvic mass oppressing the right wall of the urinary bladder was noted, which was confirmed to be a rare uterine cervical leiomyoma by biopsy.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"1243-1244"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144612127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mimicking Lymphoma: A Rare Case of Extramedullary Plasmacytoma in Lymph Nodes on 18 F-FDG PET/CT. 模拟淋巴瘤:18F-FDG PET/CT显示一例罕见的淋巴结髓外浆细胞瘤。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-07-11 DOI: 10.1097/RLU.0000000000006041
Shaoming Chen, Qianqian Xue, Zefang Lin, Qun Liu, Weibing Miao

Extramedullary plasmacytoma involving multiple lymph nodes is extremely rare. We report FDG PET/CT findings of multiple extramedullary plasmacytomas involving lymph nodes in a 71-year-old man. A chest CT scan revealed multiple enlarged lymph nodes in the right supraclavicular region, hilum, and mediastinum, merging into several soft tissue masses suggestive of lymphoma. On FDG PET/CT, these masses demonstrated intense 18 F-FDG uptake, mimicking aggressive lymphoma. No other abnormal tracer uptake was identified. Biopsy of the right supraclavicular lymph node confirmed the diagnosis of plasmacytoma.

髓外浆细胞瘤累及多个淋巴结极为罕见。我们报告一例71岁男性患者多发性髓外浆细胞瘤累及淋巴结的FDG PET/CT表现。胸部CT扫描显示右侧锁骨上区、门、纵隔多发肿大淋巴结,并合并为若干软组织肿块,提示淋巴瘤。在FDG PET/CT上,这些肿块显示强烈的18F-FDG摄取,模拟侵袭性淋巴瘤。未发现其他异常示踪剂摄取。右锁骨上淋巴结活检证实浆细胞瘤的诊断。
{"title":"Mimicking Lymphoma: A Rare Case of Extramedullary Plasmacytoma in Lymph Nodes on 18 F-FDG PET/CT.","authors":"Shaoming Chen, Qianqian Xue, Zefang Lin, Qun Liu, Weibing Miao","doi":"10.1097/RLU.0000000000006041","DOIUrl":"10.1097/RLU.0000000000006041","url":null,"abstract":"<p><p>Extramedullary plasmacytoma involving multiple lymph nodes is extremely rare. We report FDG PET/CT findings of multiple extramedullary plasmacytomas involving lymph nodes in a 71-year-old man. A chest CT scan revealed multiple enlarged lymph nodes in the right supraclavicular region, hilum, and mediastinum, merging into several soft tissue masses suggestive of lymphoma. On FDG PET/CT, these masses demonstrated intense 18 F-FDG uptake, mimicking aggressive lymphoma. No other abnormal tracer uptake was identified. Biopsy of the right supraclavicular lymph node confirmed the diagnosis of plasmacytoma.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"1231-1232"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144612133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary Scapular Metastasis as the Initial Presentation of Prostate Adenocarcinoma Detected by Ga-68 PSMA PET/CT. Ga-68 PSMA PET/CT检测单独肩胛骨转移是前列腺癌的初始表现。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-07-17 DOI: 10.1097/RLU.0000000000005983
Muhammet Halil Baltacioglu

Prostate cancer commonly metastasizes to the skeleton, with multiple bones typically affected. Solitary metastasis in the appendicular skeleton, particularly in the scapula, is exceedingly rare. We present the case of a 75-year-old man with prostate adenocarcinoma, who initially presented with scapular bone metastasis detected using Ga-68 PSMA PET/CT. Imaging revealed intense uptake in a sclerotic lesion in the left scapula, suggesting a solitary metastasis.

前列腺癌通常转移到骨骼,通常会影响多块骨骼。孤立性转移在附骨,特别是肩胛骨,是非常罕见的。我们报告了一位75岁的前列腺癌患者,他最初的表现是使用Ga-68 PSMA PET/CT检测到肩胛骨转移。影像学显示左侧肩胛骨硬化灶强烈摄取,提示单发转移。
{"title":"Solitary Scapular Metastasis as the Initial Presentation of Prostate Adenocarcinoma Detected by Ga-68 PSMA PET/CT.","authors":"Muhammet Halil Baltacioglu","doi":"10.1097/RLU.0000000000005983","DOIUrl":"10.1097/RLU.0000000000005983","url":null,"abstract":"<p><p>Prostate cancer commonly metastasizes to the skeleton, with multiple bones typically affected. Solitary metastasis in the appendicular skeleton, particularly in the scapula, is exceedingly rare. We present the case of a 75-year-old man with prostate adenocarcinoma, who initially presented with scapular bone metastasis detected using Ga-68 PSMA PET/CT. Imaging revealed intense uptake in a sclerotic lesion in the left scapula, suggesting a solitary metastasis.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e712-e713"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144658623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Publication Pressure in Nuclear Medicine. 《核医学》的出版压力。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2024-12-02 DOI: 10.1097/RLU.0000000000005608
Thomas C Kwee, Ali Aldub, Robert M Kwee

Purpose: The aims of this study were to determine the publication pressure perceived by nuclear medicine scientists and to identify associated determinants.

Patients and methods: Corresponding authors who published in Clinical Nuclear Medicine , Journal of Nuclear Medicine , or European Journal of Nuclear Medicine and Molecular Imaging between 2021 and 2023 were invited to participate in this survey study. Publication pressure was assessed using the revised Publication Pressure Questionnaire in the domains of "publication stress" (stress due to perceived pressure to publish), "publication attitude" (attitude regarding current publication culture), and "publication resources" (resources when working on publications or experiencing stress when working on publishing), with 5-point Likert scales.

Results: A total of 181 individuals participated. Median Publication Pressure Questionnaire scores in the domains "publication stress," "publication attitude," and "publication resources" were 3.33, 3.33, and 2.17, respectively. None of the researchers' characteristics were significantly associated with publication stress. Age >65 years was significantly associated with a more positive view on the publication climate (β coefficient of -0.552, P =0.007). Several variables were significantly associated with a perception of fewer factors available to alleviate publication pressure: age 45-54 years (β coefficient of 0.249, P =0.030), age 55-64 years (β coefficient of 0.421, P =0.002), associate professor position (β coefficient of 0.398, P <0.001), fellow/resident position (β coefficient of 0.355, P =0.007), <5 years of research experience (β coefficient of 0.410, P =0.026), and 5-10 years of research experience (β coefficient of 0.361, P =0.003).

Conclusions: Publication pressure among nuclear medicine scientists is appreciable. Several researcher characteristics appear to be associated with vulnerability to publication pressure.

目的:本研究的目的是确定核医学科学家感受到的发表压力,并确定相关的决定因素。患者和方法:邀请2021 - 2023年在《临床核医学》、《核医学杂志》或《欧洲核医学与分子成像杂志》上发表文章的通讯作者参与本调查研究。采用修订后的出版压力问卷对出版压力进行评估,包括“出版压力”(因感知到出版压力而产生的压力)、“出版态度”(对当前出版文化的态度)和“出版资源”(从事出版工作时的资源或从事出版工作时的压力),采用李克特5分量表。结果:共有181人参与。出版压力问卷在“出版压力”、“出版态度”和“出版资源”三个领域的得分中位数分别为3.33、3.33和2.17。没有一个研究人员的特征与发表压力显著相关。年龄在0 ~ 65岁之间的人对出版气候的看法更积极(β系数为-0.552,P = 0.007)。有几个变量与减轻发表压力的因素较少的感知显著相关:年龄45-54岁(β系数为0.249,P = 0.030)、年龄55-64岁(β系数为0.421,P = 0.002)、副教授职位(β系数为0.398,P < 0.001)、研究员/住院医师职位(β系数为0.355,P = 0.007)。结论:核医学科学家的发表压力是明显的。研究者的一些特征似乎与易受出版压力的影响有关。
{"title":"Publication Pressure in Nuclear Medicine.","authors":"Thomas C Kwee, Ali Aldub, Robert M Kwee","doi":"10.1097/RLU.0000000000005608","DOIUrl":"10.1097/RLU.0000000000005608","url":null,"abstract":"<p><strong>Purpose: </strong>The aims of this study were to determine the publication pressure perceived by nuclear medicine scientists and to identify associated determinants.</p><p><strong>Patients and methods: </strong>Corresponding authors who published in Clinical Nuclear Medicine , Journal of Nuclear Medicine , or European Journal of Nuclear Medicine and Molecular Imaging between 2021 and 2023 were invited to participate in this survey study. Publication pressure was assessed using the revised Publication Pressure Questionnaire in the domains of \"publication stress\" (stress due to perceived pressure to publish), \"publication attitude\" (attitude regarding current publication culture), and \"publication resources\" (resources when working on publications or experiencing stress when working on publishing), with 5-point Likert scales.</p><p><strong>Results: </strong>A total of 181 individuals participated. Median Publication Pressure Questionnaire scores in the domains \"publication stress,\" \"publication attitude,\" and \"publication resources\" were 3.33, 3.33, and 2.17, respectively. None of the researchers' characteristics were significantly associated with publication stress. Age >65 years was significantly associated with a more positive view on the publication climate (β coefficient of -0.552, P =0.007). Several variables were significantly associated with a perception of fewer factors available to alleviate publication pressure: age 45-54 years (β coefficient of 0.249, P =0.030), age 55-64 years (β coefficient of 0.421, P =0.002), associate professor position (β coefficient of 0.398, P <0.001), fellow/resident position (β coefficient of 0.355, P =0.007), <5 years of research experience (β coefficient of 0.410, P =0.026), and 5-10 years of research experience (β coefficient of 0.361, P =0.003).</p><p><strong>Conclusions: </strong>Publication pressure among nuclear medicine scientists is appreciable. Several researcher characteristics appear to be associated with vulnerability to publication pressure.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"1161-1167"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Focal 68 Ga-FAPI-04 Uptake in Endometriosis at the Rectouterine Pouch. 子宫内膜异位症在直肠子宫袋处的局灶68Ga-FAPI-04摄取。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-03-17 DOI: 10.1097/RLU.0000000000005846
Yuheng Zou, Haoyuan Hu, Rong Tian, Rang Wang

Endometriosis is a benign condition characterized by chronic inflammation and fibrosis. We report the findings of endometriosis at the rectouterine pouch on 68 Ga-FAPI-04 PET/CT scan in a 25-year-old woman. The finding was initially thought as peritoneal metastasis from her newly diagnosed gastric cancer. However, subsequent pathologic examination confirmed that it was endometriosis.

子宫内膜异位症是一种以慢性炎症和纤维化为特征的良性疾病。我们报告一名25岁女性在68Ga-FAPI-04 PET/CT扫描上发现子宫内膜异位症。这一发现最初被认为是她新诊断的胃癌的腹膜转移。然而,随后的病理检查证实这是子宫内膜异位症。
{"title":"Focal 68 Ga-FAPI-04 Uptake in Endometriosis at the Rectouterine Pouch.","authors":"Yuheng Zou, Haoyuan Hu, Rong Tian, Rang Wang","doi":"10.1097/RLU.0000000000005846","DOIUrl":"10.1097/RLU.0000000000005846","url":null,"abstract":"<p><p>Endometriosis is a benign condition characterized by chronic inflammation and fibrosis. We report the findings of endometriosis at the rectouterine pouch on 68 Ga-FAPI-04 PET/CT scan in a 25-year-old woman. The finding was initially thought as peritoneal metastasis from her newly diagnosed gastric cancer. However, subsequent pathologic examination confirmed that it was endometriosis.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e722-e723"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostate Adenocarcinoma Recurrence in the Vas Deferens Unveiled by 99m Tc-PSMA SPECT/CT Imaging. 99mTc-PSMA SPECT/CT显像揭示输精管前列腺癌复发。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-05-08 DOI: 10.1097/RLU.0000000000005881
Nasrin Raeisi, Amin Saber Tanha, Ramin Sadeghi, Masoumeh Dorri Giv, Vahid Reza Dabbagh Kakhki

We present a case involving a 77-year-old man with prostate cancer who underwent radical prostatectomy with negative surgical margins. After 10 years without follow-up, his serum prostate-specific antigen level increased to 2.76 ng/mL, suggesting disease recurrence. Due to limited access to 68 Ga-PSMA PET/CT, a 99m Tc-HYNIC-PSMA SPECT/CT was conducted, which identified PSMA uptake in the bilateral vas deferens, a rare site for recurrence. While recurrence in the vas deferens has been previously reported using 68 Ga-PSMA PET/CT or PET/MR, this novel experience with 99m Tc-PSMA SPECT/CT highlights its potential utility in detecting such recurrences. This is particularly relevant in low-income countries where access to PET/CT may be limited.

我们报告一例77岁男性前列腺癌患者行根治性前列腺切除术,手术切缘阴性。10年未随访,血清前列腺特异性抗原升高至2.76 ng/mL,提示疾病复发。由于接触68Ga-PSMA PET/CT的机会有限,我们进行了99mtc - hyic -PSMA SPECT/CT检查,发现双侧输精管摄取PSMA,这是一个罕见的复发部位。虽然以前使用68Ga-PSMA PET/CT或PET/MR已报道过输精管复发,但99mTc-PSMA SPECT/CT的新经验突出了其在检测此类复发方面的潜在效用。这在获得PET/CT可能有限的低收入国家尤为重要。
{"title":"Prostate Adenocarcinoma Recurrence in the Vas Deferens Unveiled by 99m Tc-PSMA SPECT/CT Imaging.","authors":"Nasrin Raeisi, Amin Saber Tanha, Ramin Sadeghi, Masoumeh Dorri Giv, Vahid Reza Dabbagh Kakhki","doi":"10.1097/RLU.0000000000005881","DOIUrl":"10.1097/RLU.0000000000005881","url":null,"abstract":"<p><p>We present a case involving a 77-year-old man with prostate cancer who underwent radical prostatectomy with negative surgical margins. After 10 years without follow-up, his serum prostate-specific antigen level increased to 2.76 ng/mL, suggesting disease recurrence. Due to limited access to 68 Ga-PSMA PET/CT, a 99m Tc-HYNIC-PSMA SPECT/CT was conducted, which identified PSMA uptake in the bilateral vas deferens, a rare site for recurrence. While recurrence in the vas deferens has been previously reported using 68 Ga-PSMA PET/CT or PET/MR, this novel experience with 99m Tc-PSMA SPECT/CT highlights its potential utility in detecting such recurrences. This is particularly relevant in low-income countries where access to PET/CT may be limited.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e700-e701"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143971801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparable Diagnostic Value of 99m Tc-FAPI-46 SPECT/CT and 18 F-FDG PET/CT in Cholangiocarcinoma: A Case Report. 99mTc-FAPI-46 SPECT/CT与18F-FDG PET/CT在胆管癌诊断中的比较价值1例
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-12-01 Epub Date: 2025-05-09 DOI: 10.1097/RLU.0000000000005877
Nasrin Raeisi, Amin Saber Tanha, Mitra Ghahraman, Kamran Aryana, Atena Aghaee

We describe a 51-year-old man with cholangiocarcinoma of the common bile duct. Initially deemed nonmetastatic, he was a candidate for curative surgery and liver transplantation. However, during laparotomy, peritoneal seeding was discovered, necessitating omentectomy and lesion resection. Following chemotherapy, the patient underwent 18 F-FDG PET/CT for re-staging, revealing uptake in the primary tumor and a right iliac bone metastasis. Subsequently, FAPI-based scintigraphy using 99m Tc-FAPI-46 as a novel conventional imaging agent demonstrated comparable uptake in both lesions. This case highlights the diagnostic potential of 99m Tc-FAPI-46 SPECT/CT as an alternative to 18 F-FDG PET/CT and 68 Ga-FAPI in cholangiocarcinoma, particularly in resource-limited settings.

我们描述了一个51岁的男性与胆总管胆管癌。最初认为无转移,他是治疗性手术和肝移植的候选人。然而,在剖腹手术中,发现腹膜播种,需要网膜切除术和病变切除术。化疗后,患者接受了18F-FDG PET/CT重新分期,显示原发肿瘤的摄取和右髂骨转移。随后,使用99mTc-FAPI-46作为新型常规显像剂,基于fapi的闪烁成像显示,两种病变的摄取相当。该病例强调了99mTc-FAPI-46 SPECT/CT作为18F-FDG PET/CT和68Ga-FAPI的替代诊断胆管癌的潜力,特别是在资源有限的情况下。
{"title":"Comparable Diagnostic Value of 99m Tc-FAPI-46 SPECT/CT and 18 F-FDG PET/CT in Cholangiocarcinoma: A Case Report.","authors":"Nasrin Raeisi, Amin Saber Tanha, Mitra Ghahraman, Kamran Aryana, Atena Aghaee","doi":"10.1097/RLU.0000000000005877","DOIUrl":"10.1097/RLU.0000000000005877","url":null,"abstract":"<p><p>We describe a 51-year-old man with cholangiocarcinoma of the common bile duct. Initially deemed nonmetastatic, he was a candidate for curative surgery and liver transplantation. However, during laparotomy, peritoneal seeding was discovered, necessitating omentectomy and lesion resection. Following chemotherapy, the patient underwent 18 F-FDG PET/CT for re-staging, revealing uptake in the primary tumor and a right iliac bone metastasis. Subsequently, FAPI-based scintigraphy using 99m Tc-FAPI-46 as a novel conventional imaging agent demonstrated comparable uptake in both lesions. This case highlights the diagnostic potential of 99m Tc-FAPI-46 SPECT/CT as an alternative to 18 F-FDG PET/CT and 68 Ga-FAPI in cholangiocarcinoma, particularly in resource-limited settings.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e695-e696"},"PeriodicalIF":9.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Nuclear Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1